ArticleCancers2022

Arterial Administration of DNA Crosslinking Agents with Restraint of Homologous Recombination Repair by Intravenous Low-Dose Gemcitabine Is Effective for Locally Advanced Pancreatic Cancer.

Hiromu Mori et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.